Characterization of inhibitory anti-duffy binding protein II immunity: Approach to plasmodium vivax vaccine development in Thailand

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Chootong, Patchanee ^a   Panichakul, Tasanee ^b   Permmongkol, Chongrak ^a   Barnes, Samantha J ^c   Udomsangpetch, Rachanee ^d   Adams, John H ^c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b SUAN DUSIT UNIVERSITY   (Thailand)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d Mahidol University   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; DUFFY BINDING PROTEIN II ANTIBODY; EPITOPE; IMMUNOGLOBULIN G ANTIBODY; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; DUFFY ANTIGEN BINDING PROTEIN, PLASMODIUM; PARASITE ANTIGEN; PROTOZOAL PROTEIN; PROTOZOON ANTIBODY; RECOMBINANT PROTEIN;

ADAPTIVE IMMUNITY; ADULT; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DIMERIZATION; DISEASE ASSOCIATION; ERYTHROCYTE KINETICS; HUMAN; HUMAN CELL; PARASITE TRANSMISSION; PLASMODIUM VIVAX MALARIA; PROTEIN LOCALIZATION; PROTEIN POLYMORPHISM; PROTEIN TARGETING; THAILAND; VACCINE PRODUCTION; AMINO ACID SEQUENCE; BIOSYNTHESIS; DRUG ANTAGONISM; ERYTHROCYTE; GENETIC POLYMORPHISM; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; PARASITOLOGY; PATHOGENICITY; PLASMODIUM VIVAX; PROTEIN TERTIARY STRUCTURE;

PLASMODIUM VIVAX;

ADULT; AMINO ACID SEQUENCE; ANTIBODIES, NEUTRALIZING; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; ERYTHROCYTES; HUMANS; MALARIA, VIVAX; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PLASMODIUM VIVAX; POLYMORPHISM, GENETIC; PROTEIN STRUCTURE, TERTIARY; PROTOZOAN PROTEINS; RECEPTORS, CELL SURFACE; RECOMBINANT PROTEINS; THAILAND;

EID: 84860482942     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035769     Document Type: Article

References (30)

1. Mendis K, Sina BJ, Marchesini P, Carter R, (2001) The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg 64: 97-106.
2. Guerra CA, Howes RE, Patil AP, Gething PW, Van Boeckel TP, et al. (2009) The international limits and population at risk of Plasmodium vivax transmission in 2009. PLoS Negl Trop Dis 4: e774.
3. WHO, (2003) The World Health Report. Geneva World Health Organization.
4. Sattabongkot J, Tsuboi T, Zollner GE, Sirichaisinthop J, Cui L, (2004) Plasmodium vivax transmission: chances for control? Trends Parasitol 20: 192-198.
5. WHO, (2001) Report of a WHO informal consulation. Report WHO/CDC/RBM/2001.33. Geneva World Health Organization.
6. Horuk R, Chitnis CE, Darbonne WC, Colby TJ, Rybicki A, et al. (1993) A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science 261: 1182-1184.
7. Barnwell JW, Galinski MR, (1995) Plasmodium vivax: a glimpse into the unique and shared biology of the merozoite. Ann Trop Med Parasitol 89: 113-120.
8. Adams JH, Hudson DE, Torii M, Ward GE, Wellems TE, et al. (1990) The Duffy receptor family of Plasmodium knowlesi is located within the micronemes of invasive malaria merozoites. Cell 63: 141-153.
9. Adams JH, Fang X, Kaslow DC, Miller LH, (1992) Identification of a cryptic intron in the Plasmodium vivax Duffy binding protein gene. Mol Biochem Parasitol 56: 181-183.
10. Adams JH, Sim BK, Dolan SA, Fang X, Kaslow DC, et al. (1992) A family of erythrocyte binding proteins of malaria parasites. Proc Natl Acad Sci U S A 89: 7085-7089.
11. Chitnis CE, Miller LH, (1994) Identification of the erythrocyte binding domains of Plasmodium vivax and Plasmodium knowlesi proteins involved in erythrocyte invasion. J Exp Med 180: 497-506.
12. Ceravolo IP, Souza-Silva FA, Fontes CJ, Braga EM, Madureira AP, et al. (2008) Inhibitory properties of the antibody response to Plasmodium vivax Duffy binding protein in an area with unstable malaria transmission. Scand J Immunol 67: 270-278.
13. Grimberg BT, Udomsangpetch R, Xainli J, McHenry A, Panichakul T, et al. (2007) Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein. PLoS Med 4: e337.
14. Michon P, Fraser T, Adams JH, (2000) Naturally acquired and vaccine-elicited antibodies block erythrocyte cytoadherence of the Plasmodium vivax Duffy binding protein. Infect Immun 68: 3164-3171.
15. King CL, Michon P, Shakri AR, Marcotty A, Stanisic D, et al. (2008) Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection. Proc Natl Acad Sci U S A 105: 8363-8368.
16. Cole-Tobian J, King CL, (2003) Diversity and natural selection in Plasmodium vivax Duffy binding protein gene. Mol Biochem Parasitol 127: 121-132.
17. Kho WG, Chung JY, Sim EJ, Kim DW, Chung WC, (2001) Analysis of polymorphic regions of Plasmodium vivax Duffy binding protein of Korean isolates. Korean J Parasitol 39: 143-150.
18. Tsuboi T, Kappe SH, Al-Yaman F, Prickett MD, Alpers M, et al. (1994) Natural variation within the principal adhesion domain of the Plasmodium vivax duffy binding protein. Infect Immun 62: 5581-5586.
19. Gosi P, Khusmith S, Khalambaheti T, Lanar DE, Schaecher KE, et al. (2008) Polymorphism patterns in Duffy-binding protein among Thai Plasmodium vivax isolates. Malar J 7: 112.
20. Riley EM, Jobe O, Blackman M, Whittle HC, Greenwood BM, (1989) Plasmodium falciparum schizont sonic extracts suppress lymphoproliferative responses to mitogens and antigens in malaria-immune adults. Infect Immun 57: 3181-3188.
21. Ho M, Webster HK, Looareesuwan S, Supanaranond W, Phillips RE, et al. (1986) Antigen-specific immunosuppression in human malaria due to Plasmodium falciparum. J Infect Dis 153: 763-771.
22. Beeson JG, Osier FH, Engwerda CR, (2008) Recent insights into humoral and cellular immune responses against malaria. Trends Parasitol 24: 578-584.
23. Xainli J, Baisor M, Kastens W, Bockarie M, Adams JH, et al. (2002) Age-dependent cellular immune responses to Plasmodium vivax Duffy binding protein in humans. J Immunol 169: 3200-3207.
24. Ohas EA, Adams JH, Waitumbi JN, Orago AS, Barbosa A, et al. (2004) Measurement of antibody levels against region II of the erythrocyte-binding antigen 175 of Plasmodium falciparum in an area of malaria holoendemicity in western Kenya. Infect Immun 72: 735-741.
25. Chootong P, Ntumngia FB, VanBuskirk KM, Xainli J, Cole-Tobian JL, et al. (2010) Mapping epitopes of the Plasmodium vivax Duffy binding protein with naturally acquired inhibitory antibodies. Infect Immun 78: 1089-1095.
26. Batchelor JD, Zahm JA, Tolia NH, (2011) Dimerization of Plasmodium vivax DBP is induced upon receptor binding and drives recognition of DARC. Nat Struct Mol Biol 18: 908-914.
27. Nobrega de Sousa T, Carvalho LH, Alves de Brito CF, (2011) Worldwide genetic variability of the Duffy binding protein: insights into Plasmodium vivax vaccine development. PLoS One 6: e22944.
28. Fraser T, Michon P, Barnwell JW, Noe AR, Al-Yaman F, et al. (1997) Expression and serologic activity of a soluble recombinant Plasmodium vivax Duffy binding protein. Infect Immun 65: 2772-2777.
29. Michon PA, Arevalo-Herrera M, Fraser T, Herrera S, Adams JH, (1998) Serologic responses to recombinant Plasmodium vivax Duffy binding protein in a Colombian village. Am J Trop Med Hyg 59: 597-599.
30. McHenry AM, Barnes SJ, Ntumngia FB, King CL, Adams JH, (2011) Determination of the molecular basis for a limited dimorphism, N417K, in the Plasmodium vivax Duffy-binding protein. PLoS One 6: e20192.